These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Scleroderma in children. Zulian F Pediatr Clin North Am; 2005 Apr; 52(2):521-45, vii. PubMed ID: 15820378 [TBL] [Abstract][Full Text] [Related]
4. Comorbidity influences therapeutic approach in multiple sclerosis. Capone F; Ferraro E; Florio L; Marcoccia A; Di Lazzaro V; Di Battista G Clin Neurol Neurosurg; 2017 Apr; 155():14-16. PubMed ID: 28212926 [No Abstract] [Full Text] [Related]
5. Systemic sclerosis. Hughes M; Herrick AL Br J Hosp Med (Lond); 2019 Sep; 80(9):530-536. PubMed ID: 31498665 [TBL] [Abstract][Full Text] [Related]
6. [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment]. Sicińska J; Rudnicka L Pol Merkur Lekarski; 2008 Aug; 25(146):192-5. PubMed ID: 18942346 [TBL] [Abstract][Full Text] [Related]
7. [Systemic sclerosis-clinical picture, diagnosis, and treatment]. Becker MO; Distler O; Maurer B Z Rheumatol; 2019 Jun; 78(5):439-457. PubMed ID: 31089800 [TBL] [Abstract][Full Text] [Related]
8. [64-year-old patient with dyspnea at rest and rapidly progressing renal failure. Systemic sclerosis with interstitial lung disease and renal crisis]. Hellmich B; Schnabel A; Gross WL Internist (Berl); 1998 Oct; 39(10):1062-8. PubMed ID: 9827376 [No Abstract] [Full Text] [Related]
9. [Do specific antifibrotic properties of immunosuppressive drugs used in the treatment of systemic sclerosis exist?]. Verrecchia F; Michel L; Keshtmand H; Wang Y; Launay D; Farge D Rev Med Interne; 2009 Nov; 30(11):955-62. PubMed ID: 19349102 [TBL] [Abstract][Full Text] [Related]
10. HIV-associated juvenile systemic sclerosis: a case report. Okong'o LO; Webb K; Scott C Semin Arthritis Rheum; 2015 Feb; 44(4):411-6. PubMed ID: 25245932 [TBL] [Abstract][Full Text] [Related]
12. Are we too lenient with immunosuppression in severe cases of Systemic Sclerosis? Siegert E; Riemekasten G Rheumatology (Oxford); 2016 Oct; 55(10):1914-6. PubMed ID: 27330162 [No Abstract] [Full Text] [Related]
14. Localized scleroderma and systemic sclerosis: is there a connection? Gupta RA; Fiorentino D Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859 [TBL] [Abstract][Full Text] [Related]
15. Current treatment options in systemic Sclerosis (Scleroderma). Stummvoll GH Acta Med Austriaca; 2002; 29(1):14-9. PubMed ID: 11899748 [TBL] [Abstract][Full Text] [Related]
16. The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients. Hatta Y; Hasegawa M; Matsushita T; Hamaguchi Y; Fujimoto M; Takehara K Mod Rheumatol; 2014 Mar; 24(2):377-9. PubMed ID: 24593219 [No Abstract] [Full Text] [Related]
17. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies. Fett N Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160 [TBL] [Abstract][Full Text] [Related]
18. Chronic leg ulceration as the presenting feature of diffuse systemic sclerosis in childhood. Wahezi DM; Ilowite NT; Kenney-Riley KM; Belamarich PF J Pediatr; 2011 Oct; 159(4):698. PubMed ID: 21784448 [No Abstract] [Full Text] [Related]
19. Systemic sclerosis. Ng SC Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127 [TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014. Young A; Khanna D Curr Opin Rheumatol; 2015 May; 27(3):241-8. PubMed ID: 25775190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]